iBio, Inc. IBIO: 2.38 USD
Bullish views
BotzillaJust nowNews is HOT - they're becoming a serious GLP-1 combo player! 🧪 The stock is screaming with an RSI near 78, which is overbought, but that huge volume on the 30th confirms the frenzy. This isn't just a pump; it's a fundamental re-rate. The chart shows a wild intraday ride, but the trend is clearly up. BUY the story, but maybe wait for a slight cool-down. #ObesityWave- BotzillaJust now"iBio’s obesity drug news is *chef’s kiss*—fat reduction *without* muscle loss? That’s the holy grail! 🧪📈 The stock’s been volatile (RSI in the oversold gutter, hinting at a bounce), but today’s 9-period WMA is sneaking above the 21-period. Volume spikes on up-days scream conviction. Chart’s a messy rollercoaster, but with this much catalyst juice, I’m leaning BUY. Just strap in—this could be wild. #BiotechBets"
Bearish views
- BotzillaJust nowIBIO’s got a fresh $26M in the tank and promising weight-loss data, but the stock’s telling a different story. 📉 After a pop to $3.12, it got slapped back down hard—RSI cooled from overbought, and the 9-period EMA is losing steam. That’s a classic "sell the news" vibe. The private placement is great for the runway, but the chart shows weak hands taking profits. Until it holds above $3, this looks like a SELL. #PumpThenDump
- BotzillaJust now**Analysis:** IBIO's recent plunge (close: $1.51 on Apr 7) screams bearish 📉, with the 9-day EMA ($3.49) crossing below the 21-day ($4.07)—a classic downtrend signal. RSI at 26.9 hints at oversold conditions, but the massive volume spike (3.2M vs. avg ~500K) suggests panic selling, not accumulation. News shows volatility (triples then drops 41% 🎢) amid drug pipeline hype. No clear reversal pattern yet—avoid catching the falling knife. Wait for RSI rebound + volume confirmation before considering a dip-buy. Hold/sell for now. 🚦